Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy - Sorbonne Université Accéder directement au contenu
Article Dans Une Revue Journal for Immunotherapy of Cancer Année : 2020

Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy

Résumé

Background: Immunogenic cell death (ICD) is a peculiar modality of cellular demise that elicits adaptive immune responses and triggers T cell-dependent immunity. Methods: Fluorescent biosensors were employed for an unbiased drug screen approach aiming at the identification of ICD enhancers. Results: Here, we discovered thiostrepton as an enhancer of ICD able to boost chemotherapy-induced ATP release, calreticulin exposure and high-mobility group box 1 exodus. Moreover, thiostrepton enhanced anticancer immune responses of oxaliplatin (OXA) in vivo in immunocompetent mice, yet failed to do so in immunodeficient animals. Consistently, thiostrepton combined with OXA altered the ratio of cytotoxic T lymphocytes to regulatory T cells, thus overcoming immunosuppression and reinstating anticancer immunosurveillance. Conclusion: Altogether, these results indicate that thiostrepton can be advantageously combined with chemotherapy to enhance anticancer immunogenicity.
Fichier principal
Vignette du fichier
e000462.full.pdf (6.13 Mo) Télécharger le fichier
Origine : Publication financée par une institution
Loading...

Dates et versions

hal-02749843 , version 1 (03-06-2020)

Identifiants

Citer

Yan Wang, Wei Xie, Juliette Humeau, Guo Chen, Peng Liu, et al.. Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy. Journal for Immunotherapy of Cancer, 2020, 8 (1), pp.e000462. ⟨10.1136/jitc-2019-000462⟩. ⟨hal-02749843⟩
35 Consultations
36 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More